HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Beauty Retailers Deliver The “Dazzle” In 2011 To Offset Dim Economy

This article was originally published in The Rose Sheet

Executive Summary

At the Fragrance Foundation’s 2011 State of the Industry event, WSL Strategic Retail Founder Wendy Liebmann discussed some of the “bold and innovative” measures retailers have taken in 2011 to increase store traffic and get consumers excited about spending on beauty.

You may also be interested in...



L’Oreal Introduces Walgreens Shoppers To La Roche-Posay, Vichy Labs

L’Oreal casts a wider net for its La Roche-Posay and Vichy Laboratoires brands, at one time available exclusively in European pharmacies, expanding to select Walgreens locations across the U.S. Brands will be supported by interactive kiosk technology to educate consumers and enhance the shopping experience.

Joyous Tidings: Holiday Fragrance Sales To Cap Strong Year

Despite a tough economy, U.S. fragrance sales are up in 2011 going into the critical holiday season, outpacing the overall beauty market for the first time in over a decade. Analysts at the Fragrance Foundation’s Nov. 17 State of the Industry event speculate on why.

Beauty Has Spectrum Of Distribution Options; Channel Reps Offer Color

With cross-channel shopping becoming the norm in a time-starved, value-seeking society, brands and vendors must be continually innovating to contend for the business of an increasingly fickle consumer.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017871

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel